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ABSTRACT 
Objective: The purpose of this investigation was to design and develop controlled release floating beads of Ketoprofenand Pantoprazole sodium. To 
determine the interaction between excipients used and to find out the nature of drug in the formulation, X-ray diffraction (XRD) and Differential 
Scanning Colorimetry (DSC) studies were performed.  
Methods: The beads were prepared by ionotropic gelation technique. Sodium alginate and HPMC E5LV was dissolved in deionized water (9:1 
sodium alginate: HPMC E5LV) at a concentration of 1-3 % w/v using gentle heat on the water bath. After getting a clear solution, an accurately 
weighed quantity of Pantoprazole sodium was added and dispersed uniformly into the solution. In a separate beaker, Ketoprofen and calcium 
carbonate (1:1, Sodium alginate: CaCl2) was dispersed in water and mixed with sodium alginate solution containing Pantoprazole sodium. The 
bubble-free sodium alginate-drug dispersion (20 ml) was added dropwise via a 22-guage hypodermic needle fitted with a 10 ml syringe into 100 ml 
of calcium chloride solution (1-2 % w/v) containing 10 % glacial acetic acid and stirred at 400 rpm for 15 min. 
Results: From the experimental study, it was concluded that optimized batch F9 showed good micromeritic properties, entrapment efficiency and 
releases the drug slowly and completely for 12 h as beads remain in floating condition throughout dissolution study that assures prepared 
formulation remain floated in the stomach without its early passing to lower Gastro-Intestinal Tract(GIT) side. The percentage of drugs release of 
Ketoprofen and Pantoprazole Sodium was 96.56% and 97.74%, respectively at 12 h. 
Conclusion: Combination of different polymer provide sustained release pattern in different concentration. Formulation F9 gives good floating 
behavior using sodium alginate and HPMC hydroxypropyl methylcellulose in different ratios. In the present study, a satisfactory attempt has been 
made to formulate gastro retentive floating beads of Ketoprofen and Pantoprazole sodium.  
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INTRODUCTION 
Gastro Retentive Drug Delivery (GRDD) devices are primarily site-
specific drug delivery systems, which gets retained in the stomach 
for a longer period of time, thus helping in the absorption of drug for 
the intended duration of time [1, 2]. Floating Drug Delivery System 
(FDDS) reside in the stomach for a longer period of time than 
conventional dosage forms after the release of drugs; the residual 
system is emptied from the stomach [3]. The contribution of floating 
drug delivery system includes; gastric retention time is increased 
because of buoyancy, site-specific drug delivery to stomach [4]. The 
real challenge in the development of an oral controlled-release drug 
delivery system is not just to sustain the drug release but also to 
prolong the presence of the dosage form within the Gastro-Intestinal 
Tract (GIT) until all the drugs is completely released at the desired 
period of time [5]. To overcome these limitations, various 
gastroretentive systems have been designed to be retained in the 
gastric region for a prolonged time. These systems include a) 
Floating systems, b) Bioadhesive systems, c) Swelling and expanding 
systems, d) High-density systems, e) Modified systems [6]. The anti-
inflammatory effects of Ketoprofen are believed to be due to 
inhibition of cyclooxygenase-2(COX-2), an enzyme involved in 
prostaglandin synthesis via the arachidonic acid pathway. 
Ketoprofen is a non-specific cyclooxygenase inhibitor, and inhibition 
of cyclooxygenase-2 (COX-2) is thought to confer some of its side 
effects, such as GI upset and ulceration. Pantoprazole sodium is a 
Proton Pump Inhibitor (PPI) that suppresses the final step in gastric 
acid production by covalently binding to the (H+, K+)ATPase enzyme 
system at the secretory surface of the gastric parietal cell. This effect 
leads to inhibition of both basal and stimulated gastric acid 
secretion, irrespective of the stimulus. The binding to the (H+, K+) 
ATPase results in a duration of antisecretory effect that persists 
longer than 12 h. for all doses tested. Response Surface Methodology 
(RSM) as a tool of designing of experiments is a widely practiced 
approach in the development and optimization of drug delivery 
devices [7–12]. The technique requires minimum experimentation 
and less time. 
MATERIALS AND METHODS 
Materials 
Ketoprofen and pantoprazole sodium were provided by Milan 
Laboratories (India) Pvt. Ltd. Maharashtra. Sodium alginate, 
hydroxypropyl methylcellulose (HPMC) and calcium chloride were 
obtained from MolyChem Thane-421503 (India) and all other 
ingredients used were of pharmaceutical grade. 
 
Table 1.1: Trial batches of formulation 
Formulation code Sodium alginate Calcium chloride HPMC K15M, HPMC K4M HPMC E5LV HPMC E6LV HPMC K100 
(% w/v) (% w/v) 
C1 2 2 1 - - - - 
C2 2 2 - 1 - - - 
C3 2 2 - - 1 - - 
C4 2 2 - - - 1 - 
C5 2 2 - - - - 1 
Pantoprazole Sodium (40 mg) and Ketoprofen (100 mg) was used in all the above formulations 
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Methods: Preparation of drug-loaded beads by manual syringe 
method 
The beads were prepared according to the composition presented in 
table 1.1. Sodium alginate was dissolved in distilled water at 60 °C in 
a water bath for 1 hour in order to obtain a clear polymer solution 
with a concentration of 2% (w/w). Different grade of HPMC was 
dispersed in the alginate solution. Cooldown the solution at room 
temperature and Pantoprazole Sodium and Ketoprofen was added 
with continued stirring with a glass rod in a bath sonicator. 
Accordingly, 10 ml syringes fitted with a needle having a size of 22 G 
were employed in the preparation of all formulation. Above solution 
was introduced dropwise into the gelling solution (2% w/v) 
aqueous calcium chloride while being gently stirred at 25 °C. The 
stirring was continued for 15 min and the calcium alginate beads 
were harvested by filtration. 
Formulation of floating beads 
The beads were prepared by ionotropic gelation technique. Sodium 
alginate and HPMC E5LV was dissolved in deionized water (9:1 
sodium alginate: HPMC E5LV) at a concentration of 1-3 % w/v using 
gentle heat on a water bath. After getting a clear solution, an 
accurately weighed quantity of Pantoprazole sodium was added and 
dispersed uniformly into the solution. In a separate beaker, 
Ketoprofen and calcium carbonate (1:1, Sodium alginate: CaCl2) was 
dispersed in water and mixed with sodium alginate solution 
containing Pantoprazole sodium. The bubble-free sodium alginate-
drug dispersion (20 ml) was added dropwise via a 22-guage 
hypodermic needle fitted with a 10 ml syringe into 100 ml of 
calcium chloride solution (1-2 % w/v) containing 10% glacial acetic 
acid and stirred at 400 rpm for 15 min. The droplets from the 
dispersion instantaneously gelled into discrete matrices upon 
contact with the solution of the gelling agent. Finally, beads were 
filtered, washed and dried at room temperature. For bead formation, 
20 ml of a 1-3 % w/v aqueous solution of sodium alginate containing 
Pantoprazole sodium and Ketoprofen was introduced dropwise 
from a glass syringe with a size-22 needle into 100 ml of an aqueous 
2 % W/V calcium chloride solution being stirred at 400 rpm. The 
stirring was continued for one hour and the calcium alginate beads 
were harvested by filtration, washed with distilled water, and air-
dried overnight [13].  
Experimental design 
A number of preliminary trials were conducted before the 
application of the design as shown above. The levels of the factors 
were also determined randomly by evaluating the dependent 
variables (responses) of trial batches. A 32 factorial design was used 
for optimizing the formulations using Design-Expert Software 
(Version-8.0.7.1). The concentration of sodium alginate (X1) and the 
concentration of calcium chloride (X2) were classified as low, 
medium and high values for independent variables as given in table 
1.2. These studied factors along with their levels and the 
corresponding responses are summarized in table 1.3. 
Methods 
A response surface method 32 factorial designs were applied to 
evaluate the relationship between the independent variables and 
their responses. Two variables and one response were involved in 
the experimental design. The dependent response factor variables 
measured were entrapment efficiency and % Floating. The 
independent variables are the concentration of alginate (X1) and the 
concentration of calcium chloride (X2). The formulation variables 
and the high and low levels of each variable were defined based on 
preliminary experiments. Center points were repeated three times 
to estimate the experimental error. The independent and dependent 
variables are shown in table and process variables and their levels 
for full-factorial design are given in table. 
  
Table 1.2: Various independent and dependent variables 
S. No. Independent variables Dependent variables 
1 X1-Sodium alginate concentration (% W/V) Y1-%Entrapment efficiency 
2 X2-Concentration of calcium chloride (% W/V) Y2-% Floating 
 
Table 1.3: Process variables and their levels for full-factorial design 
S. No. Factors Low level Middle level High level 
1 Concentration of Sodium alginate (% W/V) 1 2 3 
2 Concentration of Calcium chloride (% W/V) 1 1.5 2 
 
 
Fig. 1.1: Percentage drug entrapment efficacy pantoprazole sodium 
Design-Expert® Software
Percent drug Entrapment Efficiency of Pantaprazole
98.7699
31.1558
X1 = A: Sodium alginate conc.















































  A: Sodium alginate conc.  
  B: Calcium chloride conc.  
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RESULTS AND DISCUSSION 
Table 1.4: Evaluation parameters of different floating alginate beads 
Formulation code % Yield % Entrapment efficiency % Floating  Physical appearance 
Pantoprazole sodium (PTS) Ketoprofen (KT) 
C1 86.35±0.12 63.16±0.41 36.26±0.23 20±0.16 Oval 
C2 76.75±0.32 66.99±0.31 38.39±0.34 25±0.33 Oval 
C3 81.89±0.30 97.29±0.13 91.27±0.43 55±0.28 Round 
C4 77.97±0.16 77.37±0.22 73.29±0.31 30±0.34 Round 
C5 78.37±0.34 73.92±0.17 70.29±0.25 27±0.33 Oval 
Data from each response is presented in mean±SD (n=3) 
 
Among of the above formulations (trial batches), formulation C3 
having Hydroxy Propyl Methyl Cellulose [HPMC] E5LV polymer 
shows good entrapment efficiency 97.29% and 91.27% for 
Pantoprazole Sodium and Ketoprofen respectively. Round 
appearance but buoyancy is not good so the different ratio of 
calcium chloride was tried for better buoyancy. 
 
Table 1.5: Experimental design and results for the various measured responses of Pantoprazole Sodium and Ketoprofen beads 
Run Variables Response % Yield  
Formulation 
code 
SA Conc. (% 
W/V) (X1) 
Cal. C Conc. 
(W/V) (X2) 
% Drug EE 
(PTS) 




1 F1 1 2 31.15±0.19 23.63±0.21 65±0.32 44.40±0.32 Irregular 
2 F2 2 1.5 95.85±0.37 74.48.93±0.16 97±0.21 58.94±0.22 Round 
3 F3 3 2 98.76±0.31 68.20±0.22 95±0.42 47.6±0.25 Oval with tailing 
4 F4 2 1.5 93.72±0.26 63.62±0.17 98±0.22 46.6±0.13 Round 
5 F5 1 1.5 58.58±0.32 40.67±0.19 85±0.31 37.28±0.27 Irregular 
6 F6 2 1.5 93.17±0.21 56.06±0.16 95±0.24 32.69±0.25 Round 
7 F7 2 1.5 55.47±0.41 64.14±0.18 97±0.11 47.78±0.26 Round 
8 F8 3 1.5 86.51±0.34 62.01±0.23 100±0.32 47.11±0.23 Oval with tailing 
9 F9 2 1 97.74.18±0.15 96.5763.66±0.18 95±0.20 46.63±0.26 Round 
10 F10 2 1.5 83.48±0.15 70.76±0.22 85±0.14 46.15±0.19 Round 
11 F11 3 1 87.96±0.26 70.81±0.35 96±0.23 39.32±0.16 Rod Shaped 
12 F12 1 1 76.37±0.14 65.65±0.16 95±0.41 39.49±0.31 Irregular 
13 F13 2 2 84.01±0.31 65.60±0.17 100±0.22 57.98±0.25 Round 
Data from each response is presented in mean±SD (n=3), 3D Surface Response Graph between Sodium alginate (X1), Calcium chloride (X2) with % 
drug entrapment efficiency of pantoprazole sodium (Y1) 
 
Table 1.6: Actual Vs predicted value by ANOVA analysis 
Standard Actual Predicted  
Order Value Value Residual 
1 76.3734 80.96774 -4.59434 
2 83.184 84.81986 -1.63586 
3 87.9686 88.67199 -0.70339 
4 58.5852 61.36478 -2.77958 
5 83.48053 79.22163 4.258892 
6 86.517 97.07848 -10.5615 
7 31.1558 41.76183 -10.606 
8 84.01093 73.6234 10.38752 
9 98.7699 105.485 -6.71508 
10 55.47 79.22163 -23.7516 
11 93.72117 79.22163 14.49954 
12 97.47394 79.22163 18.2523 
13 93.17078 79.22163 13.94915 
 
Table 1.7: ANOVA for response surface factorial model: analysis of variance table of Ketoprofen drug entrapment efficiency 
Anova SS DF MS F-value P-value   
Model 1533.693 3 511.231 5.518152 0.0199 significant 
Sodium Alginate Conc. (X1) 841.8526 1 841.8526 9.086831 0.0146  
B-Calcium Chloride Conc.(X2) 303.5476 1 303.5476 3.276448 0.1037  
AB 388.2929 1 388.2929 4.191176 0.0709  
Residual 833.8081 9 92.64534    
Adjusted R2 0.530415 
Standard Deviation 9.625245 
Coefficient of Variance (%) 15.82291 
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Fig. 1.2: Percentage drug entrapment efficacy of Ketoprofen 
 
Final factorial equation for the process 




. X1 − β2. X2+β3. X1
. X2 
% Drug Entrapment Efficiency of Ketoprofen
=  60.831 + 11.8452. X1 − 7.112. X2
+ 9.852. X1. X2 
3D Surface Response Graph between Sodium alginate (X1), Calcium 
chloride (X2) with % Drug Content of Ketoprofen (Y1) 
Determination of percent yield and drug entrapment efficiency 
Beads (100 mg) were crushed in a glass mortar and suspended in 20 
ml of 0.1N HCl. After 24 h, the solution was filtered through 0.45 mm 
membrane filter, and the filtrate was analyzed for drug content [14]. 
 
Buoyancy test 
The buoyancy of the beads is study at 37±0.5 °C, soaking 100 beads 
in 100 ml of 0.1 HCl at pH 1.2. The number of floating beads is 
evaluated at fixed time intervals. The floating time is considered as 
the time at which the 100 % of beads floated. All the data are the 
average of at least three determinations [15] 
Scanning electron microscopy 
The samples were coated with a thin gold layer by a sputter coater 
unit (SPI, sputter, USA). Then, SEM photographs were taken by a 
scanning electron microscope (Joel JSM 5400LV SEM, Japan) 
operated at an acceleration voltage of 15 kV[16]. The morphological 
evaluation of the optimized beads formulation was done by scanning 
electron microscopy. SEM study revealed that the microspheres 
were almost spherical in shape with a rough outer surface. 
 
 
Fig. 1.3: Shape and size of the beads 
 
The scanning electron microscopy (SEM) image of the beads has 
been used to examine surface topography, the texture and 
morphology of fractured surfaces are compared to hypothesize the 
mechanism of drug release and floating.  
Differential scanning calorimetry (DSC) studies 
Differential Scanning Calorimetry (DSC) is a useful tool to monitor 
the effect of additives on the structure of a material and to obtain 
information about the physicochemical interaction between drug 
and polymer. Differential Scanning Calorimetry (DSC) of drugs, 
polymer and statistically optimized formulation were carried out 
using a Mettler Toledo Star SW 8.10, Model no: DSC 822 instrument. 
In this process, samples (8–10 mg) were weighed into aluminum 
pans and heated under nitrogen from 5 to 250 °C [17]. 
X-ray diffraction (XRD) studies 
To understand the crystalline state of the drug in the polymer 
matrix, the X-ray diffraction pattern of drug-loaded beads was 
performed and compared with that of pure drug. Powder forms of 
the samples were exposed to Cu radiation (30kv×15mA) in a wide-
angle X-ray diffractometer (Miniflex gonio Meter, Japan). The 
instrument was operated in continuous mode in increments of 1 
°/min and scanned over a 2 Ɵ range of 10 to 90 °C [18]. 
In vitro drug release studies 
The in vitro drug release studies of different formulations 
(Formulation-2 and Formulation-9) and pure drugs were conducted 
to ensure the effect of sodium alginate concentration and calcium 
chloride concentration on the release of Pantoprazole Sodium and 
Ketoprofen from the formulations. The in vitro dissolution studies of 
the floating formulations were carried out using USP dissolution test 
apparatus I (basket method). The basket of USP dissolution test 
apparatus I, each containing a number of beads equivalent to 40 mg 
Pantoprazole Sodium and 100 mg Ketoprofen, were rotated at 100 
rpm in 900 ml of 0.1N HCl maintained at 37 °C±0.5 °C. An aliquot of 
5 ml of the solution was withdrawn at predetermined time intervals. 
Design-Expert® Software
Percent drug Entrapment Efficiency of Ketoprofen
75.9317
23.6359
X1 = A: Sodium alginate conc.


















































  A: Sodium alginate conc.    B: Calcium chloride conc.  
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Fig. 1.4: DSC curve of pantoprazole sodium, DSC curve of Ketoprofen, DSC curve of Sodium alginate, DSC curve of 
Ketoprofen+Pantoprazole Sodium+Sodium Alginate+Calcium chloride, DSC Thermogram of optimized formulation 
 
 
Fig. 1.5: XRD of pantoprazole sodium, XRD of the physical mixture, X-ray diffraction of optimized formulation 
 
Table 1.8: Percentage drug release of formulations 













0.25 29.79±0.24 28.66±0.31 16.29±0.20 14.10±0.31 15.82±0.40 11.51±0.39 
0.5 41.89±0.32 39.24±0.17 25.04±0.14 23.35±0.15 31.64±0.13 21.62±0.36 
1 68.86±0.13 52.63±0.18 35.37±0.18 30.08±0.16 40.01±0.12 28.43±0.27 
2 75.39±0.21 68.61±0.27 43.74±0.16 37.36±0.22 48.40±0.23 44.88±0.28 
3 77.25±0.11 69.08±0.32 53.98±0.15 46.29±0.32 61.43±0.15 53.34±0.14 
4     62.35±0.37 52.63±0.41 69.81±0.22 64.38±0.23 
5     67.01±0.26 60.62±0.22 76.33±0.26 72.37±0.15 
6     79.11±0.41 67.67±0.27 82.85±0.28 84.11±0.26 
7     84.69±0.20 70.72±0.28 86.57±0.21 85.76±0.33 
8     87.48±0.38 72.60±0.29 90.29±0.11 88.34±0.25 
9     88.41±0.11 73.07±0.21 93.09±0.32 91.40±0.13 
10     93.99±015 73.78±0.23 96.81±0.22 95.86±0.11 
11     93.99±0.7 74.01±0.32 96.81±0.21 96.57±0.21 
12     95.85±0.37 74.48±0.16 97.74±0.15 96.57±0.18 
DR: Drug release, Data from each response is presented in mean±SD (n=3) 
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Fig. 1.6: In vitro drug release of different optimized formulations and pure drug in 0.1 N HCl 
 
Discussion: Prepared floating beads shows almost spherical in shape 
with the rough outer surface, but high loaded beads were not 
smooth as low drug-loaded beads as their surface was covered by 
drug crystals. Differential Scanning Calorimetry (DSC) therms 
showed relatively broad melting endothermic peak, indicate that 
only a small fraction of drugs substance existed in the crystalline 
state. A small sized particle leads to high surface energy, which 
creates an energetically suboptimal state causing a decrease in the 
melting point. X-ray diffraction analysis showed the stable character 
of drug in the drug-loaded hollow beads and revealed the absence of 
any drug-polymer interactions. X-ray diffraction (XRD) indicates the 
amorphous dispersion of the drug after entrapment into microbeads 
may increase the bioavailability of drugs. The optimized formulation 
F9 showed 97.74% and 96.57% drug release for Pantoprazole 
sodium and ketoprofen, respectively, optimized formulation 
indicated goof floating characteristics. The in vitro dissolution 
studies of the formulation formulation-9 shows maximum percent 
cumulative release with in 12 h. This shows that Formulation-9 was 
having the good sustained release of the Pantoprazole Sodium and 
Ketoprofen up to the 12 h. 
CONCLUSION 
In the present study, a satisfactory attempt has been made to 
formulate gastroretentive floating beads of Pantoprazole sodium 
and Ketoprofen. From the experimental study result, it was 
concluded that optimized batch showed good micromeritic 
properties, entrapment efficiency and releases drug slowly and 
completely for 12 h as beads remain in floating condition 
throughout dissolution study that assures prepared formulation 
remain floated in stomach without its early passing to lower GIT 
side. This will help to increase the residence time of Pantoprazole 
sodium and Ketoprofen in stomach and achieve sustained release 
thereby increase the bioavailability of drugs. Finally the prepared 
floating beads may prove to be potential gastroretentive delivery 
system for safe and effective controlled release for an extended 
period of time. 
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